Nausea, heartburn, indigestion, upset stomach — anemia? Frequent sufferers of gastrointestinal symptoms may be doing more harm than good every time they reach for certain over-the-counter medications ...
Proton pump inhibitors (PPIs) — used widely to reduce stomach acid and treat heartburn — have been linked to an increased risk for ischemic stroke in a new study. The Danish nationwide observational ...
PRISM BioLab Co., Ltd. ("PRISM") and Receptor.AI Inc. today announced that they have entered into a drug discovery collaboration agreement (the "Collaboration") to develop an integrated, AI-navigated, ...
While 50%-80% of PPI prescriptions are unjustified, particularly for unnecessary nonsteroidal anti-inflammatory drug (NSAID)-related ulcer prophylaxis, PPIs remain underprescribed for patients at risk ...
Prolonged use of acidity medicines may carry health risks, highlighting the importance of careful prescribing and periodic review.
Many individuals struggle with heartburn on a regular basis. Patients often use proton pump inhibitors (PPIs) and H2 blockers, to eliminate chest and stomach burning symptoms. The medications decrease ...
NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global proton pump inhibitors (PPIs) market size is estimated to grow by USD 819.5 million from 2025-2029, ...
WASHINGTON (Reuters) - People who suffer a heart attack nearly double the risk of having another if they are taking the widely used blood thinner Plavix together with a heartburn drug like Prilosec, ...
Pharmaceutical Technology on MSN
PRISM BioLab partners with Receptor.AI for molecule discovery
The collaboration targets disease areas where conventional small molecule drug discovery has faced challenges.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果